ADESHWAR.BO · BSE
Adeshwar Meditex Limited
₹16.35
+0.00% (₹0)
Prev. close
₹16.35
Volume
12,000
As of
15 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Adeshwar Meditex Limited
Adeshwar Meditex Limited manufactures, processes, exports, distributes, and supplies medical consumables and healthcare solutions in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUS, NITROHEAL, PIVIDINE POVITULLE, POVIZOLE, FRAMITULLE, FUSITULLE, CALGINATE-AG SILVINET, HYDRASOOTHE, POLYBANE, and POLYBANE-N brands; combine dressings, such as eye pads under the COMBIDRESS and COMBIPAD brands; and gauze dressing and cotton products, such as cotton stockinette, kneecaps, cast paddings under the ORTHOWRAP brand, rolled cotton bandages, absorbent cotton wool, abdominal pads, gauze swabs, and triangular bandages. It also provides plasters comprising elastic adhesive bandages under the A + M PLAST brand, cohesive bandages under the GLUBAN brand, adhesive tapes under the M Tape brand, microporous tapes under the AMPORE brand, synthetic casts, plaster of paris bandages under the A + MEDISET brand, capsicum belladonna perforated plasters, and cotton crepe bandages under the A + M CREPE brand; antiseptics/disinfectants under the BIODEX-C, BIO CLEAN, VILON-N, Pividine, Pividine-S, BENZ VETOL, Pividine-C, and BID QUAT brands; examination gloves and medical kits, surgical blades and blood lancets. In addition, it offers medical bandages, such as elastic, adhesive and non-adhesive tapes, such as medicated and non-medicated, military dressings, orthopedic bandages, soft products and equipment, sanitary napkins, infusion sets and allied products, antiseptic solutions, disinfectants, hand sanitizers, ointments, rectified spirit, extra neutral ethyl alcohol, and alcohol based products, sterile home based newborn and other kits, face masks, caps, gowns, face shield, PPE kits, HIV kits, hospital protective wears and disposables, laboratory reagents, and testing kits. It serves hospitals, medical centers, households, and schools; and the automobile and defense industries. The company was founded in 1951 and is based in Mumbai, India.
Details
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Krishnojirao Nagaraja Rao
Headquarters
Mumbai
Employees
24
Website
adeshwarmeditex.comExchange
View on BSE ↗Key stats
Market cap
₹23.60 Cr
P/E ratio (TTM)
18.6
EPS (TTM)
₹0.88
Beta (1Y · daily vs NIFTY 50)
0.03
Beta (5Y · monthly vs NIFTY 50)
1.07
Shares float
25.21 L
Financial Performance
01 · Financials
Revenue for Mar 2022–Mar 2022 is as filed with BSE (standalone), and the first plotted growth figure is computed against Mar 2021 revenue as filed with BSE; the two sources' revenue definitions differ by 0.1% on Mar 2023. FY22 growth needs FY21 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹65.97 Cr | ₹64.76 Cr | ₹82.31 Cr | ₹79.75 Cr | ₹83.67 Cr | ₹56.07 Cr | |
| EBITDA | ₹5.02 Cr | ₹3.60 Cr | ₹5.39 Cr | ₹5.11 Cr | ₹4.51 Cr | ₹2.83 Cr |
| ₹1.68 Cr | ₹79.30 L | ₹2.07 Cr | ₹2.01 Cr | ₹2.07 Cr | ₹1.26 Cr | |
| Diluted EPS | — | ₹0.55 | ₹1.44 | ₹1.39 | ₹1.43 | — |
Depreciation & amortisation, Pretax income, Tax provision, Interest expense, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹67.00 Cr | ₹64.04 Cr | ₹72.20 Cr | ₹50.22 Cr | |
| — | — | ₹16.43 Cr | ₹13.89 Cr | ₹12.46 Cr | ₹6.00 Cr | |
| Stockholders' equity | — | — | ₹32.91 Cr | ₹34.91 Cr | ₹36.96 Cr | ₹38.28 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹5.77 Cr | ₹3.84 Cr | ₹3.80 Cr | ₹4.97 Cr | |
| Investing cash flow | — | — | ₹-1.16 Cr | ₹-22.31 L | ₹-25.85 L | ₹9.59 L |
| Financing cash flow | — | — | ₹-4.63 Cr | ₹-4.36 Cr | ₹-2.66 Cr | ₹-7.09 Cr |
| Capital expenditure | — | — | ₹-1.20 Cr | ₹-43.05 L | ₹-15.57 L | ₹-8.23 L |
| End cash position | — | — | ₹1.90 Cr | ₹1.16 Cr | ₹2.04 Cr | ₹1.49 L |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.41 L Cr | ₹1,868.9 | 36.5 | 5.27 | 13.7% | 0.06 | +11.9% | +12.9% |
| Divi's Laboratories Limited | ₹2.49 L Cr | ₹9,410.5 | 84.7 | 14.85 | 15.3% | 0.00 | +12.3% | +51.8% |
| Torrent Pharmaceuticals Limited | ₹1.84 L Cr | ₹4,970 | 77.5 | 21.95 | 25.8% | 1.79 | +21.5% | +36.9% |
| Apollo Hospitals Enterprise Limited | ₹1.29 L Cr | ₹8,912 | 61.7 | 13.57 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.25 L Cr | ₹683.85 | 188.8 | 14.29 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,161 | 25.8 | 4.27 | 18.6% | 0.46 | +18.4% | +11.9% |
| Cipla Limited | ₹1.13 L Cr | ₹1,386.1 | 33.4 | 3.27 | 11.3% | 0.02 | +2.1% | -12.0% |
| Laurus Labs Limited | ₹1.06 L Cr | ₹2,017.5 | 96.2 | 19.92 | 16.8% | 0.48 | +22.0% | +116.4% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Aurobindo Pharma Limited | ₹99,770.53 Cr | ₹1,713.4 | 27.1 | 2.63 | 9.2% | 0.21 | +6.4% | +53.1% |
| Dr. Reddy's Laboratories Limited | ₹98,709.15 Cr | ₹1,198.3 | 29.8 | 2.62 | 11.4% | 0.21 | +3.2% | -9.3% |
| Adeshwar Meditex Limited | ₹23.60 Cr | ₹16.35 | 18.6 | 0.62 | 3.3% | 0.16 | -33.0% | -0.6% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.